Study of Safety, Tolerability, Preliminary Efficacy of Intra-articular LNA043 Injections in Patients With Articular Cartilage Lesions.



Status:Recruiting
Conditions:Hospital
Therapuetic Areas:Other
Healthy:No
Age Range:18 - 55
Updated:1/30/2019
Start Date:September 12, 2017
End Date:September 16, 2019
Contact:Novartis Pharmaceuticals
Email:Novartis.email@novartis.com
Phone:1-888-669-6682

Use our guide to learn which trials are right for you!

A Randomized, Placebo-controlled, Patient and Investigator Blinded, Study Investigating the Safety, Tolerability and Preliminary Efficacy of Intra-articular LNA043 Injections in Regenerating the Articular Cartilage of the Knee in Patients With Articular Cartilage Lesions.

The purpose of this study is to assess the efficacy, safety and tolerability of multiple
intra-articular (i.a.) injections of LNA043 over 4-weeks, in regenerating the articular
surface in patients with cartilage lesions of the knee.


Inclusion criteria

- Patient is ≥18 and ≤55 years old at time of screening.

- Patient has a body mass index (BMI) <30 kg/m2 at screening, for patients with BMI >30
but ≤ 33kg/m2, eligibility will be decided by consultation with the sponsor.

- Patient has a symptomatic, single, articular cartilage defect of one knee, grade II or
IIIA according to the ICRS classification, localized to either the femoral
condyles/femoral trochlea or to the patella, based on MRI or arthroscopy performed
within 9 months before screening visit and confirmed by screening 3T MRI.

- Patient has an onset of pain and impairment of function between two (2) months and two
(2) years before screening.

- Patient reports a KOOS (sports and recreational activities subscale) score of ≤ 60 at
both screening and Day 1.

Exclusion criteria

- Women of child-bearing potential, defined as all women physiologically capable of
becoming pregnant, unless they are using highly effective methods of contraception
during dosing and for 15 days after stopping of investigational drug.

- Regular smokers (> 5 cigarettes/day). Urine cotinine levels will be measured during
screening for all patients. Regular smokers will be defined as any patient who reports
tobacco use of > 5 cigarettes/day and/or who has a urine cotinine ≥ 500 ng/mL.

- Patient has radiologically apparent degenerative joint disease in the target knee as
determined by Kellgren and Lawrence grade ≥2 based on X-ray evaluation performed
within 9 months from screening.

- Patient has had surgical treatment of the target knee using mosaicplasty,
microfracture, meniscectomy >50% (Note: prior diagnostic arthroscopy with debridement
and lavage, <50% meniscectomy, lateral release, patellar realignment, medial
patellofemoral ligament reconstruction are acceptable if performed at least 2 months
prior to screening; anteriorcruciate ligament reconstrucion is acceptable if performed
12 months prior to screening, or less if restoration of joint function is evident, and
agreed by the sponsor).

- Patient has an unstable target knee joint or insufficiently reconstructed ligaments
based on medical history and physical examination by the investigator.

- Patients with patellofeoral dysplasia Dejour and patients with malalignment, X-ray
requirement not limited to 9 months.

- Patient has patellofemoral dysplasia Dejour Grade B-D based on X-ray evaluation
performed within 9 months from screening.

- Patient has malalignment (valgus- or varus-deformity) in the target knee ≥ 5° based on
X-ray evaluation performed within 9 months from screening. In suspected cases, the
mechanical axis must be established radiographically through complete leg imaging
during standing and in postero-anterior (PA) projection.

Prohibited medication updated with reference to dosing (formerly screening).
We found this trial at
9
sites
La Mesa, California 91942
?
mi
from
La Mesa, CA
Click here to add this to my saved trials
Boise, Idaho 83712
?
mi
from
Boise, ID
Click here to add this to my saved trials
Brno, Czech Republic 66250
?
mi
from
Brno,
Click here to add this to my saved trials
Chicago, Illinois 60612
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Greenwood, Indiana 46143
?
mi
from
Greenwood, IN
Click here to add this to my saved trials
Longwood, Florida 32750
?
mi
from
Longwood, FL
Click here to add this to my saved trials
Miami Lakes, Florida 33014
?
mi
from
Miami Lakes, FL
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19102
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phoenix, Arizona 85012
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials